Evaluation of a Novel Reverse Thermosensitive Polymer for Use in Microvascular Surgery

ABSTRACT

Microvascular clamps have several potential shortcomings, including the risk of vessel injury. LeGoo™, a novel reverse thermosensitive polymer (Pluromed Inc., Woburn, MA), is investigated as a substitute to vascular clamping in a microsurgical model and the technical details are described. Femoral vessels of Sprague Dawley rats were used to evaluate the usefulness of this polymer for performing end-to-end arterioarterial (AA), venovenous (VV), and end-to-side arteriovenous (AV) microvascular anastomoses. The ability to obtain and maintain hemostasis was assessed. Secondary endpoints, including polymer volume, concentration, temperature, infusion technique, ability to reinfuse, blood vessel stenting effect, polymer dissolution characteristics, and reestablishment of flow, were also noted. Initial hemostasis occurred in every case. Mean duration of efficacy (hemostasis) after initial injection was 17.8 minutes (4 minutes to 44.5 minutes) for AA anastomoses and 31.8 minutes (13 minutes to 46 minutes) for VV anastomoses. Mean volume of polymer initially injected was 0.11 mL (0.01 mL to 0.20 mL) and 0.07 mL (0.06 mL to 0.10 mL) for AA and AV arteries, respectively, and 0.14 mL (0.10 mL to 0.20 mL) and 0.20 mL (0.15 mL to 0.27 mL) for VV and AV veins. Use of LeGoo in veins was clearly superior to arterial use with regard to the technical aspects of injecting LeGoo and reestablishing hemostasis, as well as greater vessel stenting effect and less vessel retraction. This novel polymer showed promise for its ability to allow for hemostasis while performing microvascular anastomoses. Improvements were made with regard to injection techniques, appropriate volumes, ability to reliably determine gel plug dissolution, and final vessel patency. Preliminary results demonstrate that this polymer may be a viable substitute for microvascular clamps.

Microvascular clamps - reverse thermosensitive polymers - poloxamer 407 - hemostasis - endothelial injury

REFERENCES

• 1 Friedman S G. A History of Vascular Surgery. Mt. Kisco, NY; Futura 1989: 4-18
• 2 Carrel A, Guthrie C G. Uniterminal and biterminal venous transplantations.  Surg Gynecol Obstet. 1906;  2 266-286
• 3 Potts W J. A new clamp for surgical division of the patent ductus arteriosus.  Q Bull Northwest Univ Med Sch. 1948;  22 321-324
• 4 Acland R. New instruments for microvascular surgery.  Br J Surg. 1972;  59 181-184
• 5 Narayanan K, Liang M D, Shichman D. A new variable-pressure microvascular clamp.  Microsurgery. 1988;  9 52-54
• 6 de Carolis V, Kuljis R. A simple adjustable microvascular clamp with a controllable gentle occlusion mechanism.  Plast Reconstr Surg. 1982;  70 100-103
• 7 Barone G W, Conerly J M, Farley P C et al.. Assessing clamp related vascular injuries by measurement of associated vascular dysfunction.  Surgery. 1989;  105 465-471
• 8 Moore W M, Manship L L, Bunt T J. Differential endothelial injury caused by vascular clamps and vessel loops: I. Normal vessels.  Am Surg. 1985;  51 392-400
• 9 Manship L L, Moore W M, Bynoe R, Bunt T J. Differential endothelial injury caused by vascular clamps and vessel loops: II. Atherosclerotic vessels.  Am Surg. 1985;  51 401-406
• 10 Slayback J B, Bowen W W, Hinshaw D B. Intimal injury from arterial clamps.  Am J Surg. 1976;  132 183-188
• 11 Ross R. The pathogenesis of atherosclerosis: an update.  N Engl J Med. 1986;  314 488-499
• 12 Jackiewicz T A, McGeachie J K, Tennant M. Structural recovery of small arteries following injury: a light and electron microscopic investigation in the rat.  Microsurgery. 1996;  17 674-680
• 13 Reeve L E. The poloxamers: their chemistry and medical applications. In: Domb AJ, Kost J, Wiseman DM Handbook of Biodegradable Polymers. Amsterdam, The Netherlands; Harwood Academic Publishers 1997: 231-247
• 14 Culbreth P H, Emanuele R M, Hunter R L. New polyoxypropylene-polyoxyethylene block copolymers for treating tissue damage by ischaemia or reperfusion, stroke, myocardial damage and adult respiratory distress syndrome: Microbial Infection. European Patent WO 9216484 1992
• 15 Raymond C. Copolymer, undergoing trials, could improve fibrinolytics' effectiveness.  JAMA. 1989;  261 2475-2480
• 16 Steinleitner A, Lambert H, Kazensky C et al.. Poloxamer 407 as an intraperitoneal barrier material for the prevention of postsurgical adhesion formation and reformation in rodent models for reproductive surgery.  Obstet Gynecol. 1991;  77 48-52
• 17 Kataoka K, Kwon G S, Yokoyama M, Okano T, Sakurai Y. Block copolymer micelles as vehicles for drug delivery.  J Control Release. 1993;  24 119-132
• 18 Raymond J, Metcalfe A, Salazkin I et al.. Temporary vascular occlusion with poloxamer 407.  Biomaterials. 2004;  25 3983-3989
• 19 Bouchot O, Aubin M C, Carrier M et al.. Temporary coronary artery occlusion during off-pump coronary artery bypass grafting with the new poloxamer P407 does not cause endothelial dysfunction in epicardial coronary arteries.  J Thorac Cardiovasc Surg. 2006;  132 1144-1149
• 20 Boodhwani M, Cohn W E, Feng J et al.. Safety and efficacy of a novel gel for vascular occlusion in off-pump surgery.  Ann Thorac Surg. 2005;  80 2333-2337
• 21 Boodhwani M, Feng J, Mieno S et al.. Effects of purified poloxamer 407 gel on vascular occlusion and the coronary endothelium.  Eur J Cardiothorac Surg. 2006;  29 736-741
• 22 Dumortier G, Grossiord J L, Agnely F et al.. A review of poloxamer 407 pharmaceutical and pharmacological characteristics.  Pharm Res. 2006;  23 2709-2728
• 23 Kim I Y, Yoo M K, Seo J H et al.. Evaluation of semi-interpenetrating polymer networks composed of chitosan and poloxamer for wound dressing application.  Int J Pharm. 2007;  341 35-43
• 24 Justicz A G, Farnsworth W V, Soberman M S et al.. Reduction of myocardial infarct size by poloxamer 188 and mannitol in a canine model.  Am Heart J. 1991;  122 671-680
• 25 Blonder J M, Baird L, Fulfs J C, Rosenthal G J. Dose-dependant hyperlipidemia in rabbits following administration of poloxamer 407 gel.  Life Sci. 1999;  65 PL261-PL266
• 26 Abe T, Sasaki M, Nakajima H et al.. Evaluation of Pluronic f127 as a base for gradual release of anticancer drug.  Gan To Kagaku Ryoho. 1990;  17 1546-1550
• 27 Pec E A, Wout Z G, Johnston T P. Biological activity of urease formulated in poloxamer 407 after intraperitoneal injection in the rat.  J Pharm Sci. 1992;  81 626-630
• 28 Bouchot O, Steinmetz E, Berne J et al.. Novel use of a gel for temporary vascular occlusion during surgery of small vessels in human: preliminary results. Paper presented at: International Society for Minimally Invasive Cardiothoracic Surgery June 11, 2008 Boston, MA;